NeuroKaire - Crunchbase Company Profile & Funding

Q: Where is NeuroKaire's headquarters?

NeuroKaire is located in Tel Aviv-yafo, Tel Aviv, Israel.

Q: Who invested in NeuroKaire?

NeuroKaire has 8 investors including Meron Capital And GreyBird Ventures.

Q: When was the last funding round for NeuroKaire?

NeuroKaire closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has NeuroKaire raised to date?

NeuroKaire has raised obfuscated.

Overview

NeuroKaire

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+4 more milestones

See more interactive data and historical milestones on desktop for the best experience

About NeuroKaire

CB Rank

45579

NeuoKaire develops a personalized medical testing tool to better treat depression.

Founded

obfuscation

Private

Venture - Series Unknown

Tel Aviv-yafo, Tel Aviv, Israel

11-50

www.neurokaire.com/

Health Care

Personal Health

Psychology

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Grant

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Daphna Laifenfeld: Co-founder & CSO
Past Role: Teva Pharmaceuticals, Head, Personalized Medicine & Diagnostics
Talia Solal: CEO

Details

Legal Name

GenetikaPlus Ltd.

Also Known As

Genetika+

Operating Status

Active

Company Type

For Profit

Founders

Daphna Laifenfeld, Talia Solal

About the Company

NeuoKaire (formerly Genetika+) is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The Genetika+ test uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.

Predictions & Insights

Growth Insight

See this Growth Insight

NeuroKaire is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

Personalized Neuronal Testing Platform

A platform that generates patient-specific neurons from blood samples to test drug efficacy for psychiatric and neurological conditions.

Comprehensive Biobank and Data Repository

A large-scale databank combining imaging, genomic, and clinical data from patient-derived neurons and diverse patient profiles.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - NeuroKaire	3	obfuscated obfuscation	GreyBird Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NeuroKaire	3	obfuscated obfuscation	GreyBird Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NeuroKaire	3	obfuscated obfuscation	GreyBird Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NeuroKaire	3	obfuscated obfuscation	GreyBird Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NeuroKaire	3	obfuscated obfuscation	GreyBird Ventures	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - NeuroKaire	3	obfuscated obfuscation	GreyBird Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NeuroKaire	3	obfuscated obfuscation	GreyBird Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NeuroKaire	3	obfuscated obfuscation	GreyBird Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NeuroKaire	3	obfuscated obfuscation	GreyBird Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NeuroKaire	3	obfuscated obfuscation	GreyBird Ventures	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Meron Capital	—	Venture Round - NeuroKaire	—
Meron Capital	—	Venture Round - NeuroKaire	—
Meron Capital	—	Venture Round - NeuroKaire	—
Meron Capital	—	Venture Round - NeuroKaire	—
Meron Capital	—	Venture Round - NeuroKaire	—